| Literature DB >> 33357700 |
Abouzar Najafi1, Hossein Daghigh Kia2, Hamed Hamishehkar3.
Abstract
Oxidative stress could be prevented by antioxidant-loaded nanoparticles. The purpose of this study was to assess the effects of 10 (A10), 20 (A20), 30 (A30), 40 (A40), and 50 (A50) μM alpha-lipoic acid and alpha-lipoic acid nanostructured lipid carriers (ALN) at 10 (ALN10), 20 (ALN20), 30 (ALN30), 40 (ALN40), and 50 (ALN50) μM on post-thawed sperm quality, fertility, and apoptosis-related genes of rooster sperm. The extender supplemented with ALN30 led to higher total and progressive motility, straight-line velocity, and linearity in comparison to the control group. The ALN30 resulted in higher percentage of mitochondria activity and glutathione peroxidase level compared with control (P < 0.05). The extender supplemented with ALN30 led to lower percentage of apoptotic sperm, when compared with the control. CASPASE 3 expression in ALN30 was lower (P < 0.05) than the other groups. The results showed that BCL-2 mRNA expression of sperm was significantly (P < 0.05) higher in ALN30 compared with the other groups (P < 0.05). Higher percentages of fertility and hatchability rates were observed in ALN30 group. The results indicate that ALN30 could be regarded as a novel potential cryoprotectant for the cryopreservation of rooster semen. Therefore, nanostructured lipid carriers improve not only the active compound (such as alpha-lipoic acid) of biomedical applicability but also the potential for industrial application in sperm cryopreservation.Entities:
Keywords: alpha-lipoic acid; apoptosis; gene; nanostructured lipid carriers; sperm
Mesh:
Substances:
Year: 2020 PMID: 33357700 PMCID: PMC7772701 DOI: 10.1016/j.psj.2020.10.007
Source DB: PubMed Journal: Poult Sci ISSN: 0032-5791 Impact factor: 3.352
Composition of the Beltsville extender.
| Ingredient | Amount |
|---|---|
| Potassium citrate tribasic monohydrate (mM) | 2.08 |
| Sodium-L-glutamate (mM) | 51.28 |
| Magnesium chloride anhydrous (mM) | 0.35 |
| D-(−)-Fructose (mM) | 27.75 |
| Potassium phosphate dibasic trihydrate (mM) | 43.57 |
| Potassium phosphate monobasic (mM) | 5.14 |
| N-[Tris (hydroxymethyl) methyl]-2 (mM) | 13.95 |
| Sodium acetate trihydrate (mM) | 3.9 |
| Soybean lecithin (g/100 mL) | 1 |
| pH | 7.1 |
| Osmolality (mOsm/kg) | 310 |
Primer sequences used for quantitative real-time polymerase chain reaction.
| Gene | Primer sequence (5′–3′) | Product size (bp) | Accession no. |
|---|---|---|---|
| GAPDH | F: ATCACAGCCACACAGAAGACG | 120 | |
| R: GACTTTCCCCACAGCCTTAGC | |||
| CASPASE 3 | F: AACCAGCCTTTTCAGAGGTGAC | 119 | |
| R: CTGGTCCACTGTCTGCTTCAATA | |||
| BCL-2 | F: AACATTGCCACCTGGATGAC | 118 | |
| R: CGAACAAAGGCCTCATACTGT |
Effect of different levels of alpha-lipoic acid and ALN on motility parameters of rooster sperm assessed by CASA after freeze-thawing.
| Treatments | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Parameters | Control | A10 | A20 | A30 | A40 | A50 | ALN10 | ALN20 | ALN30 | ALN40 | ALN 50 | SEM |
| TM (%) | 50.1b | 52.3c | 56.5b | 59.8b | 54.3b | 41.2c | 53.4b | 60.1b | 72.1a | 56.3b | 45.2b,c | 2.1 |
| PM (%) | 17.1c | 20.2b,c | 24.3b | 27.4a,b | 23.7b,c | 16.4c | 25.7a,b | 27.9a,b | 33.2a | 26.3a,b | 16.5c | 1.3 |
| VAP (μm/s) | 30.4 | 33.4 | 34.2 | 34.7 | 32.4 | 29.3 | 34.7 | 35.2 | 36.9 | 34.5 | 29.8 | 2.5 |
| VSL (μm/s) | 16.7b | 17.4b | 19.3a,b | 20.1a,b | 18.3a | 16.2b | 18.5a,b | 20.6a,b | 24.3a | 20.1a,b | 16.4b | 1.7 |
| VCL (μm/s) | 53.2 | 54.1 | 55.3 | 56.2 | 53.8 | 51.0 | 54.7 | 55.5 | 57.1 | 54.0 | 51.8 | 2.3 |
| LIN (%) | 31.4b | 32.5b | 35.0a,b | 35.9a,b | 33.9a,b | 31.3b | 33.9a,b | 36.2a | 42.5a | 36.1a,b | 31.4b | 2.1 |
Different superscripts within the same row indicate significant differences among groups (P < 0.05).
Extender supplemented with different levels of alpha-lipoic acid containing 10 (A10), 20 (A20), 30 (A30), 40 (A40), and 50 (A50) μM and alpha-lipoic acid loaded nanostructured lipid carriers (ALN) containing 10 (ALN10), 20 (ALN20), 30 (ALN30), 40 (ALN40), and 50 (ALN50) μM.
Abbreviations: LIN, linearity; PM, progressive motility; TM, total motility; VSL, straight-line velocity; VAP, average path velocity; VCL, curvilinear velocity.
Effect of different levels of alpha-lipoic acid and ALN on plasma membrane functionality and abnormal forms of rooster thawed semen.
| Parameters | Treatments | SEM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control | A10 | A20 | A30 | A40 | A50 | ALN10 | ALN20 | ALN30 | ALN40 | ALN50 | ||
| Membrane integrity (%) | 45.2c,d | 47.2b,c | 51.2b,c | 58.3b | 50.2b,c | 38.7d | 48.1b,c | 57.3b | 69.3a | 52.1b,c | 40.1c,d | 1.9 |
| Abnormal forms (%) | 19.3 | 17.7 | 17.0 | 16.9 | 16.1 | 20.4 | 17.5 | 16.4 | 14.3 | 16.6 | 19.8 | 2.2 |
Different superscripts within the same row indicate significant differences among groups (P < 0.05).
Extender supplemented with different levels of alpha-lipoic acid containing 10 (A10), 20 (A20), 30 (A30), 40 (A40) and 50 (A50) μM and alpha-lipoic acid loaded nanostructured lipid carriers (ALN) containing 10 (ALN10), 20 (ALN20), 30 (ALN30), 40 (ALN40) and 50 (ALN50) μM.
Figure 1Effect of different levels of alpha-lipoic acid and ALN on mitochondria activity of rooster thawed semen. Extender supplemented with different levels of alpha-lipoic acid containing 10 (A10), 20 (A20), 30 (A30), 40 (A40) and 50 (A50) μM and alpha-lipoic acid loaded nanostructured lipid carriers (ALN) containing 10 (ALN10), 20 (ALN20), 30 (ALN30), 40 (ALN40) and 50 (ALN50) μM. Columns with different superscript (a, b, and c) indicate differences (P < 0.05).
Effect of different levels of alpha-lipoic acid and ALN on live, apoptotic, and dead spermatozoa in rooster thawed semen, as assessed by flow cytometry.
| Parameters | Treatments | SEM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control | A10 | A20 | A30 | A40 | A50 | ALN10 | ALN20 | ALN30 | ALN40 | ALN50 | ||
| Live (%) | 45.3c | 52.2b,c | 55.3b,c | 60.1b | 52b | 40.2d | 53.6b,c | 59.1b | 70.2a | 55.2b,c | 41d | 2.6 |
| Early apoptosis (%) | 26a | 24.3a,b | 23.2a,b | 16.5b | 24.6a,b | 27.3a | 23.5ab | 19.5a,b | 14.2b | 22a,b | 27.1a | 1.9 |
| Dead (%) | 28.7a,b | 23.5b,c | 21.5c | 21.4c | 23.4b,c | 32.5a | 22.9c | 21.4c | 15.6d | 22.8c | 31.9a | 1.3 |
Viable (%, AnnexinV−/PI−)), apoptotic (%, AnnexinV+/PI−)) and dead (%, PI+) parameters were analyzed. Different superscripts within the same row indicate differences among groups (P < 0.05).
Extender supplemented with different levels of alpha-lipoic acid containing 10 (A10), 20 (A20), 30 (A30), 40 (A40) and 50 (A50) μM and alpha-lipoic acid loaded nanostructured lipid carriers (ALN) containing 10 (ALN10), 20 (ALN20), 30 (ALN30), 40 (ALN40) and 50 (ALN50) μM.
Abbreviation: PI, propidium iodide.
Figure 2Effect of different levels of alpha-lipoic acid and ALN on MDA level of rooster thawed semen. Extender supplemented with different levels of alpha-lipoic acid at 10 (A10), 20 (A20), 30 (A30), 40 (A40) and 50 (A50) μM and alpha-lipoic acid loaded nanostructured lipid carriers (ALN) at 10 (ALN10), 20 (ALN20), 30 (ALN30), 40 (ALN40) and 50 (ALN50) μM. Columns with different superscript (a, b, and c) indicate differences (P < 0.05). Abbreviation: MDA, malondialdehyde.
Effect of different levels of alpha-lipoic acid and ALN on malondialdehyde concentration (MDA), glutathione peroxidase (GPx), and superoxide dismutase (SOD) activities and total antioxidant capacity (TAC) of rooster thawed semen.
| Parameters | Treatments | SEM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Control | A10 | A20 | A30 | A40 | A50 | ALN10 | ALN20 | ALN30 | ALN40 | ALN50 | ||
| GPx (U/mg protein) | 53.2c | 55.3b,c | 57.5b | 60.2a,b | 57.2a,b | 51.1c | 56.3b | 60.0a,b | 64.8a | 58.1a,b | 52.9c | 1.8 |
| SOD (U/mg) | 106.2 | 108.2 | 112.3 | 114.5 | 107.3 | 104.4 | 109.6 | 113.2 | 116.7 | 112.3 | 106.8 | 8.4 |
| TAC (mmol/l) | 1.2c,d | 1.3b,c,d | 1.4b,c | 1.7a,b | 1.4b,c | 1.0d | 1.3b,c,d | 1.6a,b | 1.8a | 1.5a,b,c | 1.3b,c,d | 0.1 |
Different superscripts within the same row indicate significant differences among groups (P < 0.05).
Extender supplemented with different levels of alpha-lipoic acid containing 10 (A10), 20 (A20), 30 (A30), 40 (A40) and 50 (A50) μM and alpha-lipoic acid loaded nanostructured lipid carriers (ALN) containing 10 (ALN10), 20 (ALN20), 30 (ALN30), 40 (ALN40) and 50 (ALN50) μM.
Figure 3Effect of different levels of alpha-lipoic acid and ALN on relative CASPASE 3 expression of rooster thawed semen. Extender supplemented with different levels of alpha-lipoic acid at 10 (A10), 20 (A20), 30 (A30), 40 (A40) and 50 (A50) μM and alpha-lipoic acid loaded nanostructured lipid carriers (ALN) at 10 (ALN10), 20 (ALN20), 30 (ALN30), 40 (ALN40) and 50 (ALN50) μM. Columns with different superscript (a, b, and c) indicate differences (P < 0.05).
Figure 4Effect of different levels of alpha-lipoic acid and ALN on relative BCL-2 expression of rooster thawed semen. Extender supplemented with different levels of alpha-lipoic acid at 10 (A10), 20 (A20), 30 (A30), 40 (A40) and 50 (A50) μM and alpha-lipoic acid loaded nanostructured lipid carriers (ALN) at 10 (ALN10), 20 (ALN20), 30 (ALN30), 40 (ALN40) and 50 (ALN50) μM. Columns with different superscript (a, b, c, and d) indicate differences (P < 0.05).
Effect of 30 μM alpha-lipoic acid, 30 μM alpha-lipoic acid-loaded NLC, and control group on fertility and hatchability rates of rooster semen after freeze-thawing.
| Parameters | Treatments | ||
|---|---|---|---|
| Control | ALN30 | A30 | |
| Fertilized eggs | 18 (36)b | 29 (58)a | 25 (50)a |
| Hatched eggs | 8 (16)c | 23 (46)a | 17 (34)b |
| Hatched eggs ratio (hatched/fertilized, %) | 44.4b | 79.31a | 68.0a |
Different superscripts letters within row are significantly different (P < 0.05).
Each experimental group contained 50 eggs initially. Extender supplemented with alpha-lipoic acid containing 30 (A30) and alpha-lipoic acid loaded nanostructured lipid carriers (ALN) containing 30 (ALN30) μM.